4 months on tirzepatide Month Weigh-In Update 4 months. 46 lbs down.

As a thyroid hormone receptor agonist, resmetirom improves hepatic steatosis, inflammation, and fibrosis while providing lipid and cardiovascular benefits

Biochemistry 80, 701713

Medical Supervision Requirements: Legitimate programs require healthcare provider evaluation before initiating therapy and ongoing medical oversight throughout treatment

Lower CRP levels in response to semaglutide indicate that the drug might help to reduce overall inflammation, although more research is needed to confirm whether these effects apply specifically to joint inflammation in RA patients

doi: 10.2147/CPAA.S374741 137 MahapatraMKKaruppasamyMSahooBM